Skip to main content

Antiplatelet therapy: Clopidogrel-PPI interaction, an ongoing controversy.

Publication ,  Journal Article
Gurbel, PA; Tantry, US
Published in: Nat Rev Cardiol
January 2011

Duke Scholars

Published In

Nat Rev Cardiol

DOI

EISSN

1759-5010

Publication Date

January 2011

Volume

8

Issue

1

Start / End Page

7 / 8

Location

England

Related Subject Headings

  • Risk Assessment
  • Proton Pump Inhibitors
  • Practice Guidelines as Topic
  • Platelet Aggregation Inhibitors
  • Humans
  • Evidence-Based Medicine
  • Drug Interactions
  • Clinical Trials as Topic
  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gurbel, P. A., & Tantry, U. S. (2011). Antiplatelet therapy: Clopidogrel-PPI interaction, an ongoing controversy. Nat Rev Cardiol, 8(1), 7–8. https://doi.org/10.1038/nrcardio.2010.185
Gurbel, Paul A., and Udaya S. Tantry. “Antiplatelet therapy: Clopidogrel-PPI interaction, an ongoing controversy.Nat Rev Cardiol 8, no. 1 (January 2011): 7–8. https://doi.org/10.1038/nrcardio.2010.185.
Gurbel PA, Tantry US. Antiplatelet therapy: Clopidogrel-PPI interaction, an ongoing controversy. Nat Rev Cardiol. 2011 Jan;8(1):7–8.
Gurbel, Paul A., and Udaya S. Tantry. “Antiplatelet therapy: Clopidogrel-PPI interaction, an ongoing controversy.Nat Rev Cardiol, vol. 8, no. 1, Jan. 2011, pp. 7–8. Pubmed, doi:10.1038/nrcardio.2010.185.
Gurbel PA, Tantry US. Antiplatelet therapy: Clopidogrel-PPI interaction, an ongoing controversy. Nat Rev Cardiol. 2011 Jan;8(1):7–8.

Published In

Nat Rev Cardiol

DOI

EISSN

1759-5010

Publication Date

January 2011

Volume

8

Issue

1

Start / End Page

7 / 8

Location

England

Related Subject Headings

  • Risk Assessment
  • Proton Pump Inhibitors
  • Practice Guidelines as Topic
  • Platelet Aggregation Inhibitors
  • Humans
  • Evidence-Based Medicine
  • Drug Interactions
  • Clinical Trials as Topic
  • Cardiovascular System & Hematology
  • 3201 Cardiovascular medicine and haematology